ArriVent BioPharma, Inc. filed documents with the Securities and Exchange Commission (Bangladesh) on July 2, 2025, utilizing services from Citigroup and Broadridge Financial Solutions.
1 report, 0 independent
Updated Jul 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ArriVent BioPharma, Inc. filed documents with the Securities and Exchange Commission (Bangladesh) on July 2, 2025, utilizing services from Citigroup and Broadridge Financial Solutions.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Broadridge Financial Solutions
American corporate services company
Nothing else this week.
-
Securities and Exchange Commission (Bangladesh)
government regulatory body overseeing the stock market
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet